190 related articles for article (PubMed ID: 15315976)
1. Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities.
Chen G; Zeng W; Miyazato A; Billings E; Maciejewski JP; Kajigaya S; Sloand EM; Young NS
Blood; 2004 Dec; 104(13):4210-8. PubMed ID: 15315976
[TBL] [Abstract][Full Text] [Related]
2. Recurrent Abnormal Clones in Myelodysplastic Syndrome Marrow Originate from Cells at a Pluripotent Stem Level and Maintain Their Early Differentiation Potency.
Qi H; Qingxia Z; Xiao L; Lingyun W; Feng X; Zheng Z; Chunkang C
Cancer Invest; 2015; 33(8):369-77. PubMed ID: 26135215
[TBL] [Abstract][Full Text] [Related]
3. Fas-mediated apoptosis is important in regulating cell replication and death in trisomy 8 hematopoietic cells but not in cells with other cytogenetic abnormalities.
Sloand EM; Kim S; Fuhrer M; Risitano AM; Nakamura R; Maciejewski JP; Barrett AJ; Young NS
Blood; 2002 Dec; 100(13):4427-32. PubMed ID: 12393649
[TBL] [Abstract][Full Text] [Related]
4. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology.
Bernell P; Jacobsson B; Nordgren A; Hast R
Leukemia; 1996 Apr; 10(4):662-8. PubMed ID: 8618444
[TBL] [Abstract][Full Text] [Related]
5. Involvement and functional impairment of the CD34(+)CD38(-)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8.
Nilsson L; Astrand-Grundström I; Anderson K; Arvidsson I; Hokland P; Bryder D; Kjeldsen L; Johansson B; Hellström-Lindberg E; Hast R; Jacobsen SE
Blood; 2002 Jul; 100(1):259-67. PubMed ID: 12070035
[TBL] [Abstract][Full Text] [Related]
6. CD34 cells from patients with trisomy 8 myelodysplastic syndrome (MDS) express early apoptotic markers but avoid programmed cell death by up-regulation of antiapoptotic proteins.
Sloand EM; Pfannes L; Chen G; Shah S; Solomou EE; Barrett J; Young NS
Blood; 2007 Mar; 109(6):2399-405. PubMed ID: 17090657
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of the clone size in MDS cases with monosomy 7 or 7q deletion, trisomy 8, 20q deletion and loss of Y chromosome.
Mallo M; Luño E; Sanzo C; Cervera J; Haase D; Schanz J; García-Manero G; del Cañizo C; Sanz GF; Solé F
Leuk Res; 2011 Jun; 35(6):834-6. PubMed ID: 21269692
[TBL] [Abstract][Full Text] [Related]
8. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
[TBL] [Abstract][Full Text] [Related]
9. Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.
Pellagatti A; Cazzola M; Giagounidis A; Perry J; Malcovati L; Della Porta MG; Jädersten M; Killick S; Verma A; Norbury CJ; Hellström-Lindberg E; Wainscoat JS; Boultwood J
Leukemia; 2010 Apr; 24(4):756-64. PubMed ID: 20220779
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence in situ hybridization of progenitor cells obtained by fluorescence-activated cell sorting for the detection of cells affected by chromosome abnormality trisomy 8 in patients with myelodysplastic syndromes.
Saitoh K; Miura I; Takahashi N; Miura AB
Blood; 1998 Oct; 92(8):2886-92. PubMed ID: 9763574
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic analysis in patients with myelodysplastic syndrome.
Hu N; Bian M
Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(3):135-9. PubMed ID: 2098765
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic analysis of CD34+ subpopulations in AML and MDS characterized by the expression of CD38 and CD117.
Haase D; Feuring-Buske M; Schäfer C; Schoch C; Troff C; Gahn B; Hiddemann W; Wörmann B
Leukemia; 1997 May; 11(5):674-9. PubMed ID: 9180291
[TBL] [Abstract][Full Text] [Related]
13. Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality.
Dimitriou M; Woll PS; Mortera-Blanco T; Karimi M; Wedge DC; Doolittle H; Douagi I; Papaemmanuil E; Jacobsen SE; Hellström-Lindberg E
Oncotarget; 2016 Nov; 7(45):72685-72698. PubMed ID: 27683035
[TBL] [Abstract][Full Text] [Related]
14. Conventional and molecular cytogenetic features of myelodysplastic syndrome in China.
Chen L; Li J; Zhu Y; Qiu H; Pan J; Wang R; Qian S; Xu W; Xue Y
Exp Oncol; 2007 Dec; 29(4):299-303. PubMed ID: 18199987
[TBL] [Abstract][Full Text] [Related]
15. [Chromosomal aberrations in myelodysplastic syndrome].
Ol'shanskaia IuV; Domracheva EV; Udovichenko AI; Vodinskaia LA; Zakharova AV; Parovichnikova EN; Tsvetaeva NV; Mikhaĭlova EA; Glasko EN; Kolosova LIu; Kokhno AN; Tikhonova LIu; Shitareva TV; Smirnova EA; Alimova GA; Shirin AD; Vinogradova OIu; Khoroshko ND; Savchenko VG
Ter Arkh; 2005; 77(7):27-33. PubMed ID: 16116905
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of minimal residual disease in acute myelogenous leukemia and myelodysplastic syndromes in complete remission by molecular cytogenetics of progenitor cells.
Engel H; Drach J; Keyhani A; Jiang S; Van NT; Kimmel M; Sanchez-Williams G; Goodacre A; Andreeff M
Leukemia; 1999 Apr; 13(4):568-77. PubMed ID: 10214863
[TBL] [Abstract][Full Text] [Related]
17. Growth advantage of CD34+ cells in trisomy 8 high-risk myelodysplastic syndrome despite enhanced apoptotic signals.
Youssef SR; Ismail MM; Abd Al Wahed E; Al Dessoky H
East Mediterr Health J; 2012 Oct; 18(10):1065-71. PubMed ID: 23301363
[TBL] [Abstract][Full Text] [Related]
18. Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow.
Hofmann WK; de Vos S; Komor M; Hoelzer D; Wachsman W; Koeffler HP
Blood; 2002 Nov; 100(10):3553-60. PubMed ID: 12411319
[TBL] [Abstract][Full Text] [Related]
19. Combined immunophenotyping and DNA in situ hybridization to study lineage involvement in patients with myelodysplastic syndromes.
Kibbelaar RE; van Kamp H; Dreef EJ; de Groot-Swings G; Kluin-Nelemans JC; Beverstock GC; Fibbe WE; Kluin PM
Blood; 1992 Apr; 79(7):1823-8. PubMed ID: 1558974
[TBL] [Abstract][Full Text] [Related]
20. FISH analysis of circulating CD34+ cells as a new tool for genetic monitoring in MDS: verification of the method and application to 27 MDS patients.
Braulke F; Schanz J; Jung K; Shirneshan K; Schulte K; Schuetze C; Steffens R; Trümper L; Haase D
Leuk Res; 2010 Oct; 34(10):1296-301. PubMed ID: 20226527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]